tyrosine kinase

As has become clear among many people, tyrosine kinase can be involved in some unfortunate things.

Tyrosine kinase causes your body to make too many white blood cells.

Protein tyrosine kinase plays a role in this task, too.

Tyrosine kinase function has been observed in the nuclear matrix.

It belongs to the large class of tyrosine kinase receptors.

A number of viruses target tyrosine kinase function during infection.

Cellular growth and reproduction may rely to some degree on tyrosine kinase.

Tyrosine kinase activity is also significantly involved in other events that are sometimes considered highly unfavorable.

Tyrosine kinase inhibitors block signals needed for tumors to grow.

A clinical trial of targeted therapy with a tyrosine kinase inhibitor.

This gene instructs blood cells to produce a protein called tyrosine kinase.

Compounds have been developed that selectively inhibit this tyrosine kinase.

Major changes are sometimes induced when the tyrosine kinase enzyme is affected by other factors.

Cancer's response to an inhibitor of tyrosine kinase was assessed in a clinical trial.

In this case, Gefitinib is the inhibitor of tyrosine kinase.

AG126 belongs to a group of tyrosine kinase inhibitors named tyrphostins.

Src is a tyrosine kinase involved in regulation of cell growth and differentiation.

Furthermore, tyrosine kinase activity has been determined to be correlated to cellular transformation.

The cells of these tumors have a growth factor receptor associated with tyrosine kinase activity.

Genistein's chief method of activity is as a tyrosine kinase inhibitor.

Often, this is a tyrosine kinase activity.

Additional instances of factor-influenced protein tyrosine kinase activity, similar to this one, exist.

The polyoma virus affects tyrosine kinase activity inside the nuclear matrix.

In this way, a certain transformation exhibited by cells is dependent on a role that tyrosine kinase demonstrates.

Incorrect tyrosine kinase function can lead to non-small cell lung cancer.